交易 Vaxcyte, Inc. - PCVX CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.26 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Vaxcyte Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 17, 2024 | 62.37 | 0.18 | 0.29% | 62.19 | 63.38 | 61.61 |
Apr 16, 2024 | 62.16 | 0.63 | 1.02% | 61.53 | 62.76 | 61.41 |
Apr 15, 2024 | 62.29 | 1.83 | 3.03% | 60.46 | 62.54 | 60.46 |
Apr 12, 2024 | 61.82 | -0.25 | -0.40% | 62.07 | 64.46 | 60.30 |
Apr 11, 2024 | 64.77 | 2.31 | 3.70% | 62.46 | 65.19 | 62.21 |
Apr 10, 2024 | 62.47 | -0.16 | -0.26% | 62.63 | 63.23 | 61.37 |
Apr 9, 2024 | 64.44 | 1.10 | 1.74% | 63.34 | 64.47 | 62.90 |
Apr 8, 2024 | 63.97 | 0.02 | 0.03% | 63.95 | 64.10 | 63.03 |
Apr 5, 2024 | 63.93 | 1.67 | 2.68% | 62.26 | 64.78 | 61.82 |
Apr 4, 2024 | 63.26 | -1.83 | -2.81% | 65.09 | 65.13 | 63.08 |
Apr 3, 2024 | 64.98 | 1.13 | 1.77% | 63.85 | 65.74 | 63.75 |
Apr 2, 2024 | 64.32 | -1.00 | -1.53% | 65.32 | 65.99 | 64.23 |
Apr 1, 2024 | 66.61 | -0.83 | -1.23% | 67.44 | 67.44 | 65.89 |
Mar 28, 2024 | 68.18 | -0.07 | -0.10% | 68.25 | 69.59 | 67.38 |
Mar 27, 2024 | 68.43 | 1.95 | 2.93% | 66.48 | 68.94 | 66.48 |
Mar 26, 2024 | 67.31 | 0.95 | 1.43% | 66.36 | 68.06 | 65.93 |
Mar 25, 2024 | 66.22 | -0.24 | -0.36% | 66.46 | 67.59 | 66.05 |
Mar 22, 2024 | 67.11 | -0.49 | -0.72% | 67.60 | 67.76 | 66.95 |
Mar 21, 2024 | 67.55 | -1.56 | -2.26% | 69.11 | 70.50 | 67.48 |
Mar 20, 2024 | 69.07 | 1.78 | 2.65% | 67.29 | 69.20 | 66.44 |
Vaxcyte, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, May 6, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q1 2024 Vaxcyte Inc Earnings Release Q1 2024 Vaxcyte Inc Earnings ReleaseForecast(預報) -返回 - |
Wednesday, June 12, 2024 | ||
時間 (UTC) 15:30 | 國家 US
| 事件 Vaxcyte Inc Annual Shareholders Meeting Vaxcyte Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Tuesday, August 6, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q2 2024 Vaxcyte Inc Earnings Release Q2 2024 Vaxcyte Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 232.3 | 103.67 | 89.581 | 54.153 | 35.533 |
銷售/一般/行政費用,總計 | 73.586 | 42.735 | 16.017 | 8.546 | 5.388 |
研究與開發 | 135.675 | 60.935 | 73.564 | 45.607 | 30.145 |
營業收入 | -232.3 | -103.67 | -89.581 | -54.153 | -35.533 |
利息收入(費用),非經營淨值 | 6.884 | 2.008 | -2.114 | 0.457 | 0.87 |
其他,淨值 | 1.931 | 1.585 | 2.478 | 3.422 | 5.178 |
稅前淨收入 | -223.485 | -100.077 | -89.217 | -50.274 | -29.485 |
稅後淨收入 | -223.485 | -100.077 | -89.217 | -50.274 | -29.485 |
未計算非常項目前的淨收益 | -223.485 | -100.077 | -89.217 | -50.274 | -29.485 |
淨收入 | -223.485 | -100.077 | -89.217 | -50.274 | -29.485 |
普通股股東可獲收益 (不含非經常性項目) | -223.485 | -100.077 | -89.217 | -50.274 | -29.485 |
普通股股東可獲收益 (含非經常性項目) | -223.485 | -100.077 | -89.217 | -50.274 | -29.485 |
攤薄淨收入 | -223.485 | -100.077 | -89.217 | -50.274 | -29.485 |
攤薄後加權平均股 | 64.878 | 51.9221 | 29.5458 | 48.3858 | 48.3858 |
扣除特別項目的每股攤薄盈利 | -3.4447 | -1.92744 | -3.01962 | -1.03902 | -0.60937 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -3.08958 | -1.92744 | -3.00946 | -1.03902 | -0.60937 |
異常費用(收入) | 23.039 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 87.147 | 71.192 | 86.617 | 58.577 | 47.886 |
銷售/一般/行政費用,總計 | 14.456 | 26.093 | 23.334 | 19.855 | 16.623 |
研究與開發 | 72.691 | 45.099 | 40.244 | 38.722 | 31.263 |
營業收入 | -87.147 | -71.192 | -86.617 | -58.577 | -47.886 |
利息收入(費用),非經營淨值 | 16.344 | 10.076 | 7.642 | 0.503 | -1.336 |
其他,淨值 | 2.464 | 0.654 | 0.925 | 0.157 | 0.69 |
稅前淨收入 | -68.339 | -60.462 | -78.05 | -57.917 | -48.532 |
稅後淨收入 | -68.339 | -60.462 | -78.05 | -57.917 | -48.532 |
未計算非常項目前的淨收益 | -68.339 | -60.462 | -78.05 | -57.917 | -48.532 |
淨收入 | -68.339 | -60.462 | -78.05 | -57.917 | -48.532 |
普通股股東可獲收益 (不含非經常性項目) | -68.339 | -60.462 | -78.05 | -57.917 | -48.532 |
普通股股東可獲收益 (含非經常性項目) | -68.339 | -60.462 | -78.05 | -57.917 | -48.532 |
攤薄淨收入 | -68.339 | -60.462 | -78.05 | -57.917 | -48.532 |
攤薄後加權平均股 | 98.0579 | 86.2068 | 79.0122 | 61.9893 | 60.8188 |
扣除特別項目的每股攤薄盈利 | -0.69693 | -0.70136 | -0.98782 | -0.93431 | -0.79798 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.69693 | -0.70136 | -0.69623 | -0.93431 | -0.79798 |
異常費用(收入) | 23.039 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 942.555 | 256.348 | 389.004 | 61.723 | 66.668 |
現金和短期投資 | 931.376 | 245.97 | 386.2 | 58.976 | 66.09 |
現金等價物 | 834.657 | 68.985 | 386.2 | 58.976 | 66.09 |
預付的費用 | 11.179 | 10.378 | 2.804 | 2.747 | 0.578 |
總資産 | 1006.18 | 324.337 | 392.826 | 65.698 | 70.802 |
物業/廠房/設備,總計 - 淨額 | 31.648 | 35.912 | 3.272 | 3.391 | 3.411 |
物業/廠房/設備,總計 - 總額 | 37.765 | 39.46 | 7.369 | 6.373 | 5.162 |
累計折舊,總計 | -6.117 | -3.548 | -4.097 | -2.982 | -1.751 |
其他長期資産,總計 | 5.426 | 4.96 | 0.55 | 0.584 | 0.723 |
流動負債總額 | 40.525 | 28.716 | 46.861 | 11.052 | 6.713 |
應付賬款 | 9.795 | 6.758 | 29.785 | 3.376 | 2.83 |
預提費用 | 30.73 | 21.958 | 17.062 | 7.657 | 3.88 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0 | 0.014 | 0.019 | 0.003 | |
負債總額 | 52.565 | 40.319 | 46.983 | 11.761 | 10.72 |
長期債務總額 | 0 | 0 | 0 | 0.45 | 3.647 |
長期債務 | 0.45 | 3.647 | |||
其他負債,總計 | 12.04 | 11.603 | 0.122 | 0.259 | 0.36 |
股權 | 953.613 | 284.018 | 345.843 | 53.937 | 60.082 |
Redeemable Preferred Stock | 160.31 | 117.81 | |||
普通股 | 0.082 | 0.056 | 0.054 | 0.007 | 0.006 |
額外實收資本 | 1476.02 | 582.844 | 544.353 | 2.967 | 1.339 |
留存收益(累計赤字) | -522.126 | -298.641 | -198.564 | -109.347 | -59.073 |
總負債和股東權益 | 1006.18 | 324.337 | 392.826 | 65.698 | 70.802 |
已發行普通股總數 | 79.4707 | 53.032 | 51.0716 | 48.3858 | 48.3858 |
短期投資 | 96.719 | 176.985 | |||
長期投資 | 26.549 | 27.117 | |||
其他權益,總計 | -0.361 | -0.241 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 1295.43 | 1310.32 | 840.674 | 942.555 | 369.759 |
現金和短期投資 | 1265.68 | 1287.06 | 822.038 | 931.376 | 362.226 |
現金等價物 | 545.134 | 531.033 | 380.451 | 834.657 | 278.401 |
短期投資 | 720.55 | 756.031 | 441.587 | 96.719 | 83.825 |
預付的費用 | 29.75 | 23.253 | 18.636 | 11.179 | 7.533 |
總資産 | 1496.06 | 1502.82 | 1008.16 | 1006.18 | 412.065 |
物業/廠房/設備,總計 - 淨額 | 27.764 | 34.426 | 34.863 | 31.648 | 32.834 |
物業/廠房/設備,總計 - 總額 | 36.148 | 42.005 | 41.691 | 37.765 | 38.249 |
累計折舊,總計 | -8.384 | -7.579 | -6.828 | -6.117 | -5.415 |
長期投資 | 168.564 | 153.726 | 127.815 | 26.549 | 3.977 |
其他長期資産,總計 | 4.295 | 4.35 | 4.811 | 5.426 | 5.495 |
流動負債總額 | 85.558 | 60.216 | 52.747 | 40.525 | 39.309 |
應付賬款 | 15.704 | 16.266 | 11.615 | 9.795 | 5.485 |
預提費用 | 69.854 | 43.95 | 41.132 | 30.73 | 33.824 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | |||||
負債總額 | 93.341 | 69.443 | 63.392 | 52.565 | 52.754 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 7.783 | 9.227 | 10.645 | 12.04 | 13.445 |
股權 | 1402.72 | 1433.38 | 944.771 | 953.613 | 359.311 |
Redeemable Preferred Stock | 0 | ||||
普通股 | 0.098 | 0.097 | 0.084 | 0.082 | 0.064 |
額外實收資本 | 2148.5 | 2086.73 | 1527.23 | 1476.02 | 803.98 |
留存收益(累計赤字) | -743.591 | -650.927 | -582.588 | -522.126 | -444.076 |
其他權益,總計 | -2.29 | -2.521 | 0.047 | -0.361 | -0.657 |
總負債和股東權益 | 1496.06 | 1502.82 | 1008.16 | 1006.18 | 412.065 |
已發行普通股總數 | 93.8469 | 93.8125 | 80.6408 | 79.4707 | 60.5727 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -223.485 | -100.077 | -89.217 | -50.274 | -29.485 |
經營活動産生的現金 | -170.597 | -121.393 | -46.628 | -47.145 | -30.466 |
經營活動産生的現金 | 2.577 | 1.8 | 1.405 | 1.232 | 1.037 |
非現金物品 | 37.574 | 13.889 | 5.914 | -2.011 | -3.913 |
已付現金利息 | 0.002 | 0.007 | 0.007 | 0.04 | 0.075 |
營運資金的變化 | 12.737 | -37.005 | 35.27 | 3.908 | 1.895 |
投資活動産生的現金 | 74.585 | -212.308 | -1.105 | -1.195 | -1.773 |
資本支出 | -5.848 | -6.555 | -1.155 | -1.195 | -1.774 |
其他投資現金流量項目,總計 | 80.433 | -205.753 | 0.05 | 0 | 0.001 |
融資活動産生的現金 | 861.547 | 17.796 | 374.87 | 41.567 | 62.19 |
股票的發行(報廢),淨額 | 862.408 | 17.796 | 378.299 | 42.942 | 62.473 |
債務的發行(退還),淨額 | 0 | 0 | -0.061 | -0.278 | -0.283 |
現金淨變化 | 765.672 | -316.344 | 327.224 | -7.114 | 29.951 |
融資現金流項目 | -0.861 | 0 | -3.368 | -1.097 | 0 |
外彙效應 | 0.137 | -0.439 | 0.087 | -0.341 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -60.462 | -223.485 | -145.435 | -87.518 | -38.986 |
Cash From Operating Activities | -47.69 | -170.597 | -105.376 | -66.828 | -27.702 |
Cash From Operating Activities | 0.712 | 2.577 | 1.875 | 1.191 | 0.582 |
Non-Cash Items | 5.288 | 37.574 | 22.147 | 14.067 | 6.308 |
Cash Interest Paid | 0 | 0.002 | 0.002 | 0.002 | 0 |
Changes in Working Capital | 6.772 | 12.737 | 16.037 | 5.432 | 4.394 |
Cash From Investing Activities | -448.101 | 74.585 | 110.537 | 75.831 | 49.666 |
Capital Expenditures | -5.609 | -5.848 | -4.701 | -3.858 | -2.92 |
Other Investing Cash Flow Items, Total | -442.492 | 80.433 | 115.238 | 79.689 | 52.586 |
Cash From Financing Activities | 41.562 | 861.547 | 204.914 | 160.897 | 111.019 |
Financing Cash Flow Items | -0.727 | -0.861 | 106.763 | 107.624 | 107.622 |
Issuance (Retirement) of Stock, Net | 42.289 | 862.408 | 98.151 | 53.273 | 3.397 |
Issuance (Retirement) of Debt, Net | 0 | ||||
Foreign Exchange Effects | 0.023 | 0.137 | -0.659 | -0.712 | -0.227 |
Net Change in Cash | -454.206 | 765.672 | 209.416 | 169.188 | 132.756 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
825 Industrial Road, Ste. 300
SAN CARLOS
CALIFORNIA 94070
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易